LiquiVida Wellness Therapy Franchise For Sale
Liquivida® is the leader in the IV vitamin therapy industry and is fully diversified in its products and services. It serves customer needs ranging from anti-aging, medical aesthetics, and weight loss, along with personal beauty and care.
The US healthcare industry is broken. But we’re partnering with the best in modern medicine to make a difference in our communities and around the world. By focusing on the larger population, we believe we can proactively keep people healthy, so they can live more active and fulfilling lifestyles.
Why LiquVida?
· Proprietary Custom I.V. Drip Technology
· Multiple Revenue Streams: Products & Services
· Comprehensive Training & Ongoing Support
· Program Affiliated with Over 4000 Doctors
· No Medical License Required
· Membership model
· Multiple revenue streams
Startup Investment Opportunities
Real Estate & Property Management Companies for Sale
Gift & Flower Shops for Sale
Finance & Accounting Businesses for Sale
Wholesale & Distribution Businesses for Sale
Cleaning & Janitorial Businesses for Sale
Post Office Businesses for Sale
Warehouse & Storage Businesses for Sale
Retail Businesses for Sale
Consulting & Training Businesses for Sale
Gift & Flower Shop Franchise Opportunities
Bars & Pubs Franchises for Sale
Entertainment & Recreation Franchise Opportunities
Environmental Franchise Opportunities
Employment & Personnel Franchise Opportunities
Smoke & Vape Shop Franchises for Sale
Finance & Accounting Franchise Opportunities
Child Care & Education Franchise Opportunities
Liquor Franchises for Sale
Fitness & Wellness Franchises for Sale
Places of Worship for Sale
Medical Buildings for Sale or Lease
Industrial Buildings for Sale or Lease
Land & Developments for Sale
Mixed Use Buildings for Sale or Rent
Commercial Spaces for Sale or Lease
Office Buildings for Sale or Rent
Apartment Buildings for Sale
Retail Spaces for Lease or Sale
Houses & Condos for Sale or Lease
An email will be sent to registered email address.
Please select if you are: